{
"amendment_scope": "rows_as_filed",
"code": "A",
"date": "2025-09-19",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person\u0027s Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."
},
"owners": [
{
"cik": "0001588395",
"name": "Mayersohn Joel David",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "321228",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "300000",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}
Optional analytics
Allow Google Analytics to measure visits and clicks on SEC source links. You can change your choice at any time.